Cytogenetic and Molecular Response to Imatinib in High Risk (Sokal) Chronic Myeloid Leukemia (CML): Results of An European Leukemianet Prospective Study Comparing 400 Mg and 800 Mg Front-Line

Baccarani M., Castagnetti F., Simonsson B., Porkka K., HAZNEDAROĞLU İ. C., Nagler A., ...More

50th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2008, vol.112, pp.75-76 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 112
  • City: San-Francisco
  • Country: Costa Rica
  • Page Numbers: pp.75-76
  • Hacettepe University Affiliated: Yes